Ruyi Xue
Overview
Explore the profile of Ruyi Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
886
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Z, Xu L, Yuan Y, Zhang S, Xue R
Semin Cancer Biol
. 2025 Feb;
110:65-82.
PMID: 39954752
Platelets, traditionally regarded as passive mediators of hemostasis, are now recognized as pivotal regulators in the tumor microenvironment, establishing metabolic feedback loops with tumor and immune cells. Tumor-derived signals trigger...
2.
Yang C, Chen H, Wu Y, Shen X, Liu H, Liu T, et al.
Anal Chem
. 2024 Dec;
97(1):271-280.
PMID: 39711466
The increasing focus of small extracellular vesicles (sEVs) in liquid biopsy has created a significant demand for streamlined improvements in sEV isolation methods, efficient collection of high-quality sEV data, and...
3.
Liu Z, Lin X, Zhang D, Guo D, Tang W, Yu X, et al.
Adv Sci (Weinh)
. 2024 Oct;
11(46):e2407517.
PMID: 39422063
Tumor immune microenvironment is strongly associated with the malignancy behavior of hepatocellular carcinoma (HCC). However, the immune function and regulatory mechanisms of B cells in HCC remain unclear. The expression...
4.
Wu H, Zhang Y, Tang W, Lv M, Chen Z, Meng F, et al.
Heliyon
. 2024 Oct;
10(19):e37664.
PMID: 39386803
Background: Clinical practice showed that many patients with SARS-CoV-2 infection presented with long COVID syndrome in digestive system. We sought to investigate the factor affecting the incidence of long COVID...
5.
Xue R, Li M, Zhang G, Zhang W, Han L, Bo T, et al.
Blood
. 2024 Oct;
144(25):2652-2665.
PMID: 39378585
Thrombotic complications due to platelet hyperreactivity are a major cause of death in patients undergoing chemotherapy. However, the underlying mechanisms are not fully understood. Herein, using human platelets and platelets...
6.
Zhang F, Jiang Q, Cai J, Meng F, Tang W, Liu Z, et al.
Sci Adv
. 2024 Oct;
10(40):eadp8266.
PMID: 39356756
The efficacy of immunotherapy targeting the PD-1/PD-L1 pathway in hepatocellular carcinoma (HCC) is limited. NOD-like receptors (NLRs) comprise a highly evolutionarily conserved family of cytosolic bacterial sensors, yet their impact...
7.
Bo T, Wang C, Yao D, Jiang Q, Zhao Y, Wang F, et al.
J Control Release
. 2024 Feb;
368:157-169.
PMID: 38367861
Gene delivery to macrophages holds great promise for cancer immunotherapy. However, traditional gene delivery methods exhibit low transfection efficiency in macrophages. The star-shaped topological structure of polymers is known to...
8.
Zhang F, Liu W, Meng F, Jiang Q, Tang W, Liu Z, et al.
J Immunother Cancer
. 2024 Jan;
12(1).
PMID: 38272562
Background: Hepatocellular carcinoma (HCC) is an exceptionally immunosuppressive malignancy characterized by limited treatment options and a dismal prognosis. Macrophages constitute the primary and heterogeneous immune cell population within the HCC...
9.
Chen Z, Tang W, Feng N, Lv M, Meng F, Wu H, et al.
EBioMedicine
. 2023 Dec;
99:104912.
PMID: 38096688
Background: Abnormal liver function was frequently observed in nonalcoholic fatty liver disease (NAFLD) patients infected with SARS-CoV-2. Our aim was to explore the effect of SARS-CoV-2 inactivated vaccines on liver...
10.
Li D, Lin X, Li J, Liu X, Zhang F, Tang W, et al.
Cancer Cell Int
. 2023 Nov;
23(1):277.
PMID: 37978523
Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, with a high mortality and poor survival rate. Abnormal tumor metabolism is considered a hallmark of HCC and...